Scarica l'app Stockscreener
2.76
0.00%
0.00
Arcadia Biosciences Inc Borsa (RKDA) Ultime notizie
Arcadia Biosciences (STU:17D) Owner Earnings per Share (TTM) : -5.72 (As of Sep. 2024) - GuruFocus.com
‘GoodWheat’: Arcadia Biosciences launches limited release of reduced-gluten non-GMO wheat flour - FoodNavigator-USA.com
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y - MSN
Arcadia Biosciences (FRA:17D) 3-Year FCF Growth Rate : 54.40% (As of Jun. 2024) - GuruFocus.com
Arcadia Biosciences (FRA:17D) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
Arcadia Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences: Q3 Earnings Snapshot - Darien Times
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Arcadia Biosciences Reports Strong Q3 2024 Growth - TipRanks
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights - Quantisnow
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
CFO takes over as CEO at Arcadia - Food Business News
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call - Quantisnow
Zacks Industry Outlook Highlights Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences - Yahoo Finance
Arcadia Biosciences stock hits 52-week high at $4 - Investing.com India
Arcadia Biosciences stock hits 52-week high at $4 By Investing.com - Investing.com South Africa
Resistant Starch Market: 2024 Global Future Scope, - openPR
ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Simplify Asset Management Inc. Buys 248,000 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Ares Capital Co. (NASDAQ:ARCC) Receives $21.71 Consensus PT from Brokerages - Defense World
Seven Eight Capital LP Trims Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
WINTON GROUP Ltd Sells 14,344 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Arcellx Sees Unusually Large Options Volume (NASDAQ:ACLX) - Defense World
Ardelyx (NASDAQ:ARDX) Trading Down 3.6% - Defense World
Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 3.5% - Defense World
Arko gains for a second day after report it's mulling sale of convenience stores - Seeking Alpha
Metric Deep Dive: Understanding Ares Capital Corp (ARCC) Through its Ratios - The Dwinnex
Aclaris Therapeutics (NASDAQ:ACRS) Receives “Neutral” Rating from HC Wainwright - Defense World
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Healthcare Company, Inc.ACHC - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming DeadlinesARDX - PR Newswire
Aclaris Therapeutics (NASDAQ:ACRS) Receives "Neutral" Rating from HC Wainwright - MarketBeat
First Week of January 2027 Options Trading For Ares Capital (ARCC) - Nasdaq
Ares Capital Co. (NASDAQ:ARCC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Ares Capital (ARCC) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Arcturus Therapeutics Holdings Inc (ARCT) expanding its growth trajectory ahead - SETE News
R1.3bn start to ARC’s financial year - Moneyweb
ARC Investments firms over 4% on strong portfolio growth - Moneyweb
Here's Why Investors Should Invest in Arcturus Stock Now - Zacks Investment Research
Recent Insider Activity Suggests Potential Gains for Arcutis Biotherapeutics Inc (ARQT) - Knox Daily
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing
Arcturus Therapeutics Holdings Inc [ARCT] Insider Activity: An Update for Investors - Knox Daily
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Rating of “Buy” by Brokerages - Defense World
ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Acadia Healthcare Company, Inc. and Encourages Investors to Contact the Firm! - PR Newswire
Arcadia Biosciences ~ SONOVA 400 - Natural Products Insider
Amendment: Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits - Quantisnow
Wheat no longer in Arcadia’s future - Food Business News
Analysts Offer Predictions for Arcadia Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:RKDA) - Defense World
0.16%
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):